In conclusion, the current pan-cancer analysis of IQGAP3 revealed that IQGAP3 was differentially expressed in tumor and normal tissues as well as the correlation of IQGAP3 expression with pathological stage, gene mutation, clinical prognosis, and DNA methylation. This evidence concerns the gene IQGAP3 and cancer.